Human Genome Epidemiology Literature Finder
|
Records 1 - 9 (of 9 Records) |
| Query Trace: Anemia and IDH2[original query] |
|---|
| Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias. BMC cancer 2010 10 (1): 401. Rocquain Julien, Carbuccia Nadine, Trouplin Virginie, Raynaud Stéphane, Murati Anne, Nezri Meyer, Tadrist Zoulika, Olschwang Sylviane, Vey Norbert, Birnbaum Daniel, Gelsi-Boyer Véronique, Mozziconacci Marie-Joel |
| Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic study of 277 patients. Leukemia 2012 Jan 26 (1): 101-5. Patnaik M M, Hanson C A, Hodnefield J M, Lasho T L, Finke C M, Knudson R A, Ketterling R P, Pardanani A, Tefferi |
| Prognostic score including gene mutations in chronic myelomonocytic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Jul 31 (19): 2428-36. Itzykson Raphaël, Kosmider Olivier, Renneville Aline, Gelsi-Boyer Véronique, Meggendorfer Manja, Morabito Margot, Berthon Céline, Adès Lionel, Fenaux Pierre, Beyne-Rauzy Odile, Vey Norbert, Braun Thorsten, Haferlach Torsten, Dreyfus François, Cross Nicholas C P, Preudhomme Claude, Bernard Olivier A, Fontenay Michaela, Vainchenker William, Schnittger Susanne, Birnbaum Daniel, Droin Nathalie, Solary Er |
| CALR mutation screening in pediatric primary myelofibrosis. Pediatric blood & cancer 2014 Dec 61 (12): 2256-62. An Wenbin, Wan Yang, Guo Ye, Chen Xiaojuan, Ren Yuanyuan, Zhang Jingliao, Chang Lixian, Wei Wei, Zhang Peihong, Zhu Xiaof |
| Acquired somatic mutations of isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) in preleukemic disorders. Blood cells, molecules & diseases 2015 Mar 54 (3): 286-91. Chotirat Sadudee, Thongnoppakhun Wanna, Wanachiwanawin Wanchai, Auewarakul Chirayu |
| Mastocytosis among elderly patients: A multicenter retrospective French study on 53 patients. Medicine 2016 Jun 95 (24): e3901. Rouet Audrey, Aouba Achille, Damaj Gandhi, Soucié Erinn, Hanssens Katia, Chandesris Marie-Olivia, Livideanu Cristina Bulai, Dutertre Marine, Durieu Isabelle, Grandpeix-Guyodo Catherine, Barète Stéphane, Bachmeyer Claude, Soria Angèle, Frenzel Laurent, Fain Olivier, Grosbois Bernard, de Gennes Christian, Hamidou Mohamed, Arlet Jean-Benoit, Launay David, Lavigne Christian, Arock Michel, Lortholary Olivier, Dubreuil Patrice, Hermine Olivier, Georgin-Lavialle Soph |
| Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature. Oncotarget 2018 Jun 9 (45): 27882-27894. Kuendgen Andrea, Müller-Thomas Catharina, Lauseker Michael, Haferlach Torsten, Urbaniak Petra, Schroeder Thomas, Brings Carolin, Wulfert Michael, Meggendorfer Manja, Hildebrandt Barbara, Betz Beate, Royer-Pokora Brigitte, Gattermann Norbert, Haas Rainer, Germing Ulrich, Götze Katharina |
| [Mutational Spectrum and Prognosis Analysis of AML Patients Based on High-Throughput Sequencing]. Zhongguo shi yan xue ye xue za zhi 2021 Apr 29 (2): 353-362. Li Jian-Xiong, Liu Heng, Sheng Hong-Xia, Zhang B |
| Prediction of Response to Erythropoiesis Stimulating Agents in Low-Risk Myelodysplastic Syndromes. Asian Pacific journal of cancer prevention : APJCP 2021 12 22 (12): 4037-4042. Hattakitpanitchakul Saroj, Kobbuaklee Sirorat, Wudhikarn Kitsada, Polprasert Chanta |
- Page last reviewed:Feb 1, 2024
- Content source: